Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Swift, LP"'
Publikováno v:
DNA Electrophoresis: Methods and Protocols.
DNA interstrand crosslinks (ICLs) are an extremely toxic form of DNA damage that cells experience upon exposure to natural metabolites. Moreover, ICLs are the cytotoxic lesion produced a range of clinically important anticancer agents. Therefore, imp
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cancer Chemotherapy & Pharmacology; Aug2008, Vol. 62 Issue 3, p471-482, 12p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Scopus-Elsevier
ResearcherID
ResearcherID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2a793bd932b5960b00d189c39fed5adf
http://www.scopus.com/inward/record.url?eid=2-s2.0-0034446971&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0034446971&partnerID=MN8TOARS
Autor:
Swift LP; Department of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom., Lagerholm BC; Wolfson Imaging Centre, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.; Cell Imaging and Cytometry Core, Turku Bioscience Centre, University of Turku and Åbo Akademi, ku, Finland., Henderson LR; Department of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom., Ratnaweera M; Department of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom., Baddock HT; Department of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.; Calico Life Sciences, South San Francisco, CA, USA., Sengerova B; Department of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic., Lee S; Department of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom., Cruz-Migoni A; Department of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom., Waithe D; Wolfson Imaging Centre, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom., Renz C; Institute of Molecular Biology gGmbH (IMB), Mainz, Germany., Ulrich HD; Institute of Molecular Biology gGmbH (IMB), Mainz, Germany., Newman JA; Centre for Medicines Discovery, University of Oxford, Oxford, United Kingdom., Schofield CJ; Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, United Kingdom., McHugh PJ; Department of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom. peter.mchugh@imm.ox.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2024 Jun 25; Vol. 15 (1), pp. 5392. Date of Electronic Publication: 2024 Jun 25.
Autor:
Bielinski M; Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford Mansfield Road Oxford OX1 3TA UK christopher.schofield@chem.ox.ac.uk., Henderson LR; Department of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital Oxford OX3 9DS UK peter.mchugh@imm.ox.ac.uk., Yosaatmadja Y; Centre for Medicines Discovery, NDM Research Building, University of Oxford Old Road Campus Research Building, Roosevelt Drive Oxford OX3 7DQ UK joseph.newman@cmd.ox.ac.uk., Swift LP; Department of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital Oxford OX3 9DS UK peter.mchugh@imm.ox.ac.uk., Baddock HT; Department of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital Oxford OX3 9DS UK peter.mchugh@imm.ox.ac.uk., Bowen MJ; Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford Mansfield Road Oxford OX1 3TA UK christopher.schofield@chem.ox.ac.uk., Brem J; Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford Mansfield Road Oxford OX1 3TA UK christopher.schofield@chem.ox.ac.uk., Jones PS; University of Dundee, European Screening Centre Newhouse ML1 5UH UK., McElroy SP; University of Dundee, European Screening Centre Newhouse ML1 5UH UK., Morrison A; University of Dundee, European Screening Centre Newhouse ML1 5UH UK., Speake M; University of Dundee, European Screening Centre Newhouse ML1 5UH UK., van Boeckel S; Pivot Park Screening Centre 5349 AB Oss The Netherlands., van Doornmalen E; Pivot Park Screening Centre 5349 AB Oss The Netherlands., van Groningen J; Pivot Park Screening Centre 5349 AB Oss The Netherlands., van den Hurk H; Pivot Park Screening Centre 5349 AB Oss The Netherlands., Gileadi O; Centre for Medicines Discovery, NDM Research Building, University of Oxford Old Road Campus Research Building, Roosevelt Drive Oxford OX3 7DQ UK joseph.newman@cmd.ox.ac.uk., Newman JA; Centre for Medicines Discovery, NDM Research Building, University of Oxford Old Road Campus Research Building, Roosevelt Drive Oxford OX3 7DQ UK joseph.newman@cmd.ox.ac.uk., McHugh PJ; Department of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital Oxford OX3 9DS UK peter.mchugh@imm.ox.ac.uk., Schofield CJ; Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford Mansfield Road Oxford OX1 3TA UK christopher.schofield@chem.ox.ac.uk.
Publikováno v:
Chemical science [Chem Sci] 2024 Apr 30; Vol. 15 (21), pp. 8227-8241. Date of Electronic Publication: 2024 Apr 30 (Print Publication: 2024).
Autor:
Emms VL; Institute for Structural and Chemical Biology, School of Chemistry, University of Leicester Henry Wellcome Building Lancaster Road Leicester LE1 7RH UK richard.hopkinson@leicester.ac.uk., Lewis LA; Institute for Structural and Chemical Biology, School of Chemistry, University of Leicester Henry Wellcome Building Lancaster Road Leicester LE1 7RH UK richard.hopkinson@leicester.ac.uk., Beja L; Institute for Structural and Chemical Biology, School of Chemistry, University of Leicester Henry Wellcome Building Lancaster Road Leicester LE1 7RH UK richard.hopkinson@leicester.ac.uk., Bulman NFA; Institute for Structural and Chemical Biology, School of Chemistry, University of Leicester Henry Wellcome Building Lancaster Road Leicester LE1 7RH UK richard.hopkinson@leicester.ac.uk., Pires E; Department of Chemistry, University of Oxford, Chemistry Research Laboratory 12 Mansfield Road Oxford OX1 3TA UK., Muskett FW; Institute for Structural and Chemical Biology, Department of Molecular and Cell Biology, University of Leicester Henry Wellcome Building Lancaster Road Leicester LE1 7RH UK., McCullagh JSO; Department of Chemistry, University of Oxford, Chemistry Research Laboratory 12 Mansfield Road Oxford OX1 3TA UK., Swift LP; Department of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital Headington Oxford OX3 9DS UK lonnie.swift@imm.ox.ac.uk peter.mchugh@imm.ox.ac.uk., McHugh PJ; Department of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital Headington Oxford OX3 9DS UK lonnie.swift@imm.ox.ac.uk peter.mchugh@imm.ox.ac.uk., Hopkinson RJ; Institute for Structural and Chemical Biology, School of Chemistry, University of Leicester Henry Wellcome Building Lancaster Road Leicester LE1 7RH UK richard.hopkinson@leicester.ac.uk.
Publikováno v:
Chemical science [Chem Sci] 2023 Sep 15; Vol. 14 (44), pp. 12498-12505. Date of Electronic Publication: 2023 Sep 15 (Print Publication: 2023).